AEON Biopharma (AEON) Return on Assets [ROA] (2021 - 2026)
AEON Biopharma's Return on Assets [ROA] was -862.63% in Q2 2026, down 853.68 percentage points from -8.95% a year earlier.
Powered by 
Analysis
AEON Biopharma (AEON) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at AEON Biopharma came in at -901.45%, down 1742.64 percentage points from FY2024.
- Return on Assets [ROA] shows a four-year change of -907.37 percentage points (FY2021 to FY2025).
- In earlier years, Return on Assets [ROA] was 841.19% in FY2024 (+4517.68 pp), -3676.49% in FY2023 (-3639.96 pp), -36.53% in FY2022 (-42.45 pp) and 5.92% in FY2021.
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2024.
- Compared with a year earlier, Return on Assets [ROA] was higher in three of the last five quarters, with an average year-over-year change of +3978.25 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.14% |
| 10 | AEON Biopharma | 12.07 Mn | -8.73 Mn | - | -862.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -862.63% |
| Dec 31, 2025 | -548.79% |
| Sep 30, 2025 | 4.84% |
| Jun 30, 2025 | -8.95% |
| Mar 31, 2025 | 2,002.41% |
| Dec 31, 2024 | 1,189.51% |
| Sep 30, 2024 | -5,294.48% |
| Jun 30, 2024 | -6,093.72% |
| Mar 31, 2024 | -9,096.76% |
| Sep 30, 2023 | -1,856.58% |
| Jun 30, 2023 | -361.81% |
| Mar 31, 2023 | -377.71% |
| Dec 31, 2022 | -28.02% |
| Sep 30, 2022 | -2.00% |
| Jun 30, 2022 | 3.81% |
| Mar 31, 2022 | 1.68% |
| Dec 31, 2021 | 0.61% |
API Access
AEON Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AEON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "AEON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AEON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();